Guardant Health logo

Guardant Health

Precision oncology company using AI and liquid biopsies for cancer diagnosis and monitoring

Redwood City, United States Founded 2012 1000-5000 employees SaaS
Visit website

About Guardant Health

Guardant Health develops blood-based cancer tests and precision oncology technologies for screening, treatment selection, and disease monitoring. Its tests analyze signals such as circulating tumor DNA and other molecular features to provide information that clinicians can use in cancer care and research. The company’s portfolio includes Shield for colorectal cancer screening, Guardant360 liquid biopsy tests for genomic profiling in advanced cancer, and Guardant Reveal for molecular residual disease and recurrence monitoring in selected cancer settings. Guardant Health also works with biopharmaceutical companies on clinical research and the development of targeted therapies and diagnostic approaches. For patients, clinicians, and researchers seeking liquid biopsy testing, blood-based cancer screening, genomic profiling, and precision oncology diagnostics, Guardant Health offers products and services across multiple stages of cancer care. Test suitability and interpretation depend on the clinical setting and should be discussed with a qualified healthcare professional.

AI Tools & Services

No AI tools listed yet.

Reviews

No reviews yet.

Similar AI Companies